Grant of United States Patent
Filed with ASX · · 1 page · English
• US Patent Office grants new patent • Patent relates to pest management using Bio-Gene molecules • Along with the other recent allowances, this extends patent protection for Bio-Gene’stechnology to 2038 and supports its core value proposition Bio-Gene Technology Limited (ASX: BGT, ‘Bio-Gene’ or ‘the ‘Company’), an agtech development company enabling the next generation of novel insecticides, toda
Bio-Gene Technology Ltd. on 6ix
Story so far
Earlier from Bio-Gene Technology
- Appendix 4D - Half Year Accounts - 31 December 2021
- Appendix 4C - 31 December 2021
- Bio-Gene Completes Capital Raising of $3.2 Million
- Bio-Gene to Progress Synergy Research
- Bio-Gene 2021 AGM - Chairmans Address
Later from Bio-Gene Technology
- Positive Stored Grain Pest Results
- Strategic Placement of $1.5 million to Cornerstone Investor
- Bio-Gene Executes Commercial Development Agreement
- Appendix 4C - 31 March 2022
- Update on Development Program with BASF
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology